U.S. Markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.92+0.16 (+9.09%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close1.76
Bid1.59 x 2500
Ask1.75 x 1100
Day's Range1.65 - 1.92
52 Week Range1.34 - 5.40
Avg. Volume212,301
Market Cap17.08M
PE Ratio (TTM)-2.21
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Should You Have Aethlon Medical Inc’s (AEMD) In Your Portfolio?
    Simply Wall St.13 days ago

    Should You Have Aethlon Medical Inc’s (AEMD) In Your Portfolio?

    If you are looking to invest in Aethlon Medical Inc’s (NASDAQ:AEMD), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • Zacks Small Cap Researchlast month

    AEMD: EAP Filed, Expect FDA Response By Mid-September

    The major highlight on the operational front since our last update (on June 30th) was submission of the anticipated application to FDA seeking EAP designation for the Hemopurifier.  In an 8-K, filed earlier this week, Aethlon disclosed that they received formal receipt from the FDA of their EAP submission.  Per FDA guidance, the agency’s goal is to make a decision within 30 days (~mid-September) whether to grant EAP designation, or in the event additional information is required, to formally request that the sponsor (i.e.

  • Forbeslast month

    Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football

    James Joyce, who played football for the Denver Broncos, is now supporting biotech research aimed at answering questions about the link between repeated head blows and dementia.